RSS
Clinical Update
Are Two Antidepressants Better Than One?
Michael Posternak, MD. Psychiatrist in private practice, Boston, MA.
Dr. Posternak has no financial relationships with companies related to this material.
General Psychiatry
Expert Q&A
Prescription Drug Misuse
Joseph Pierre, MD.
Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
Dr. Pierre has no financial relationships with companies related to this material.
Clinical Update
Auvelity: A Fast-Acting Antidepressant?
Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Dr. Aiken has no financial relationships with companies related to this material.
Research Update
Paliperidone ER vs Olanzapine for Treatment-Resistant Schizophrenia
Zachary Davis. Mr. Davis has no financial relationships with companies related to this material.
Expert Q&A
Psychedelic-Assisted Psychotherapy
Jeffrey Guss, MD.
Psychiatrist and psychoanalyst. Clinical Assistant Professor of Psychiatry at NYU Grossman School of Medicine. Faculty at the NYU Postdoctoral Program in Psychotherapy and Psychoanalysis.
Dr. Guss has no financial relationships with companies related to this material.
Clinical Update
A Psychedelic Primer
Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.
The authors have no financial relationships with companies related to this material.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
